| AGGF1 — Angiogenic Factor With G-Patch and FHA Domains 1 | |
|---|---|
| Symbol | AGGF1 |
| Full Name | Angiogenic Factor with G-Patch and FHA Domains 1 |
| Chromosome | 5q13.2 |
| NCBI Gene | 55109 |
| Ensembl | ENSG00000100985 |
| OMIM | 609589 |
| UniProt | Q9Y5K8 |
| Diseases | [Vascular Malformations](/diseases/vascular-malformations), [Moyamoya Disease](/diseases/moyamoya), [Stroke](/diseases/stroke) |
| Expression | Endothelial Cells, Brain, Heart, Lung |
Aggf1 Gene Angiogenic Factor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
AGGF1 encodes a protein with G-patch and FHA (forkhead-associated) domains that functions as an angiogenic factor. It plays important roles in vascular development and has been implicated in cerebrovascular disease and neurovascular function.
AGGF1 has several important molecular functions:
AGGF1 interacts with:
AGGF1 mutations are associated with:
Recent studies suggest AGGF1 variants may contribute to:
Given its role in vascular health:
The vascular component of AGGF1 may be relevant to:
AGGF1 is expressed in:
AGGF1 represents a potential therapeutic target for:
The neurovascular unit is a critical structure maintaining cerebral homeostasis:
AGGF1 influences the coupling between neuronal activity and blood flow:
AGGF1's role in blood-brain barrier (BBB) integrity is particularly relevant to neurodegenerative diseases[1]:
| Component | AGGF1 Effect |
|---|---|
| Tight junctions | Supports expression of claudin-5, occludin |
| Transporters | Modulates BBB transporter function |
| Endothelial viability | Promotes endothelial cell survival |
| Pericyte coverage | Supports pericyte function |
Vascular dysfunction is increasingly recognized as a key component of AD pathogenesis:
AGGF1 is directly relevant to vascular cognitive impairment:
| Strategy | Rationale |
|---|---|
| AGGF1 agonists | Enhance angiogenesis |
| VEGF modulation | Support vascular function |
| Gene therapy | AAV-mediated expression |
The blood-brain barrier is also affected in PD:
AGGF1 has particular relevance to stroke pathophysiology:
| Type | AGGF1 Role |
|---|---|
| Ischemic | Promotes post-ischemic angiogenesis |
| Hemorrhagic | May affect vascular stability |
The G-patch domain (glycine-rich RNA binding domain) suggests AGGF1 functions in RNA processing:
The FHA (forkhead-associated) domain mediates protein-protein interactions:
AGGF1 influences multiple signaling pathways:
VEGF Signaling → PI3K/Akt → Endothelial survival
↓
ANG/Tie2 → MAPK/ERK → Angiogenesis
↓
FGF Signaling → Proliferation
| Variant | Effect | Clinical Significance |
|---|---|---|
| Loss-of-function | Reduced angiogenesis | Vascular malformation risk |
| Gain-of-function | Enhanced angiogenesis | Potential cancer applications |
| Common variants | Altered expression | Stroke risk modification |
| Approach | Stage | Indication |
|---|---|---|
| Recombinant AGGF1 | Research | Stroke recovery |
| Gene therapy | Preclinical | Chronic ischemia |
| Small molecule agonists | Discovery | Vascular dementia |
| Marker | Utility | Sample Type |
|---|---|---|
| Plasma AGGF1 | Vascular function | Blood |
| CSF AGGF1 | CNS involvement | Cerebrospinal fluid |
| Expression in PBMCs | Disease activity | Blood |
AGGF1 represents a fascinating intersection of vascular biology and neurodegeneration. Its dual functionality—angiogenesis promotion through VEGF interaction and potential RNA processing via the G-patch domain—positions it as an important player in neurovascular health. The protein's involvement in blood-brain barrier maintenance, cerebral angiogenesis, and vascular malformation pathogenesis makes it a relevant therapeutic target for conditions ranging from stroke to Alzheimer's disease. Understanding AGGF1's full range of functions in the central nervous system and developing targeted therapeutic interventions hold promise for addressing the vascular components of neurodegenerative diseases.
The study of Aggf1 Gene Angiogenic Factor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.